Ultherapy for the Treatment of Spider Veins on the Legs

Status Completed

Clinical Trial Summary

Up to 30 enrolled subjects will be treated. Enrolled subjects will receive Ultherapy® treatments along each length of the spider vein. Follow-up visits will occur at 30 and 60 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Clinical Trial Description

This study is a prospective, single center, clinical trial to be conducted at one clinical site. Enrolled subjects will receive up to three Ultherapy® treatments at a single depth, 14 days apart, using a 10-1.5mm transducer. Treatment will be provided along each length of the spider vein and up to four veins will be treated per subject Maximum length of each vein treated is 2cm. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02286804
Study type	Interventional
Source	Merz North America, Inc.
Contact
Status	Completed
Phase	N/A
Start date	October 2014
Completion date	May 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03646955` - Partial Breast Versus no Irradiation for Women With Early Breast Cancer	N/A
Completed	`NCT00378196` - Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial	Phase 1
Terminated	`NCT04336163` - Skin Imaging to Inform Laser Treatments	N/A
Completed	`NCT03472859` - Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser	N/A
Completed	`NCT01491620` - Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte	N/A
Recruiting	`NCT06259292` - Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Completed	`NCT04148950` - Effects of Kinesio Taping Method on Functional Capacity and Quality of Life in Patients With Chronic Venous Disease	N/A
Completed	`NCT00457145` - Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation	Phase 1
Completed	`NCT00457067` - Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation	Phase 1
Completed	`NCT04795310` - Clinical Observation of Pulsed Dye Laser and Intense Pulsed Light in Treating Facial Telangiectasia	N/A
Completed	`NCT04274842` - D-OCT of Facial Telangiectasia Treated With IPL	N/A
Recruiting	`NCT05978986` - Efficiency of Determining the Clinical Class of Chronic Venous Disorders by Artificial Intelligence	N/A
Completed	`NCT05036200` - Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma	N/A